Kolexia
Reita Damien Pharmacien
Reita Damien
Pharmacien
Hôpital Hautepierre
Strasbourg, France
26 Activités
96 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Gliome Tumeurs du cerveau Tumeurs du poumon Carcinome pulmonaire non à petites cellules Glioblastome Carcinome pulmonaire à petites cellules Hypoxie Sarcomes Pinéalome

Collaborateurs

Voir plus
Guerin Eric
Guerin Eric
Hôpital Hautepierre, Strasbourg, France
Entz-Werle Natacha
Entz-Werle Natacha
Hôpital Hautepierre, Strasbourg, France
Lhermitte Benoit
Lhermitte Benoit
CHU Strasbourg, Strasbourg, France
Pencreach Erwan
Pencreach Erwan
Hôpital Hautepierre, Strasbourg, France

Industries

Voir plus
Pfizer
2 collaboration(s)
Dernière en 2021
The MarkeTech Group SARL
1 collaboration(s)
Dernière en 2020
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Coxal giant cell-rich tumour harbouring an NUTM1 gene fusion: a new molecular subtype of giant cell tumour of bone?
Histopathology   16 janvier 2024
CS-PEDIA: Evaluation of the Clinical and Therapeutic Impact of Large Genomic Studies at Diagnosis in Pediatric Solid Cancers
Essai Clinique (CHU Strasbourg)   12 décembre 2023
MODL-22. DEVELOPMENT OF A PATIENT-DERIVED MODEL BIOBANK TO PROVIDE AN ACCURATE TOOL DECIPHERING BRAIN TUMOR INITIATION, PROGRESSION, AND THERAPEUTIC RESISTANCE
Abstracts from the 2023 Society for Neuro-Oncology’s 28th Annual Scientific Meeting and Education Day   10 novembre 2023
DIPG-33. P16 IMMUNOHISTOCHEMICAL EXPRESSION AS A SURROGATE ASSESSMENT OF CDKN2A ALTERATION IN GLIOMAS LEADING TO PROGNOSTIC SIGNIFICANCES
Abstracts from the 2023 Pediatric Neuro-Oncology Research Conference   12 juin 2023
Glioblastoma Metabolism: Insights and Therapeutic Strategies.
International journal of molecular sciences   23 mai 2023
p16 Immunohistochemical Expression as a Surrogate Assessment of CDKN2A Alteration in Gliomas Leading to Prognostic Significances.
Cancers   28 février 2023
Molecular Heterogeneity in BRAF-Mutant Gliomas: Diagnostic, Prognostic, and Therapeutic Implications.
Cancers   16 février 2023
All pineal tumors expressing germ cell tumor markers are not necessarily germ cell tumors: histopathological and molecular study of a midline primary intracranial sarcoma DICER1-mutant.
Virchows Archiv : an international journal of pathology   28 octobre 2022
Retrospective and integrative analyses of molecular characteristics and their specific imaging parameters in pediatric grade 1 gliomas.
Pediatric blood & cancer   04 avril 2022
Direct Targeting Mutation in Non-Small Cell Lung Cancer: Focus on Resistance.
Cancers   04 mars 2022